• Provides an optimal moist wound environment conducive to wound healing and minimizes the chance of damage to healthy periwound skin
CovaWound™ Hydrocolloid is indicated for the management of lightly to moderately exuding wounds such as pressure, leg and foot ulcers, superficial partial-thickness burns, donor sites, diabetic ulcers, post-operative wounds, and skin abrasions. Dressing may also be used on small wounds toward the end of the healing phase.
Dressing should not be used on third-degree burns, clinically infected wounds, wounds at a high risk of infection, or on patients with a known allergy or sensitivity to hydrocolloids.
If sensitivity develops, discontinue use. Skin stripping may occur on patients with fragile skin. Dressing should only be used under the direction of a health care professional. If signs of infection are present, appropriate medical treatment should be initiated.
|Antimicrobial format available|
|Conforms readily to wound||●|
|Gels on contact w/ exudate||●|
|Impermeable to outside contaminants|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Non/Minimally Exudating Wounds
Clean the wound area with normal saline or distilled water. Gently dry the surrounding skin and ensure that it is free of any residue. Choose the size and shape of the dressing which is most suitable (the dressing should extend 2cm beyond the wound margin). Remove the large part of the release liner from the dressing. Center and apply the exposed part of the dressing over the wound bed. Avoid touching the adhesive surface to minimize risk of contamination. Remove the small part of the release liner from the dressing and apply. Finalize application of the dressing, making sure that the edges of the dressing adhere well. This initial adhesion will improve as the dressing warms up. If necessary, use medical tape around the edges to avoid roll-up.
CovaWound™ Hydrocolloid dressing may be left in place for up to 7 days depending on the condition of the wound and surrounding skin, or as indicated by accepted clinical practice. The cumulative use of CovaWound™ Hydrocolloid dressing should not exceed 30 days.
May be used as a secondary dressing to ColActive® Plus (Collagen Matrix Dressing) or ColActive® Plus Ag (Collagen Matrix Dressing with Silver).
Covalon Technologies researches, develops, and commercializes new health care technologies that help save lives around the world. Covalon's technologies are used to prevent, detect, and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings, and biocompatibility.